Green Mountain Care Board: Vermont health costs unsustainable as insurers, hospitals strain

The Green Mountain Care Board told state legislators on Thursday that Vermont’s health spending has outpaced the rest of the country for years and that the board’s authority is limited to a narrow slice of insurance and hospital financing.

“The role of the GMCB ... is often sometimes confused,” Owen Foster, chair of the Green Mountain Care Board, told the committee. “We are an independent agency ... and we're quasi judicial.”

The board used a two-hour presentation to outline what it regulates — hospital budgets, certificates of need and rate increases on qualified health plans — and what it does not, including Medicare, Medicaid, Medicare Advantage and most self‑insured employer plans. Foster emphasized that the board directly regulates only the qualified health plan market, which covers roughly 60,000 people in Vermont, a fraction of the state’s total insured lives.

Why it matters: the board said Vermont faces a sustainability crisis. Commercial prices and insurer claims have spiked recently while access and population health measures have not improved in step. Blue Cross Blue Shield of Vermont, the state’s dominant insurer, has reported multi‑million‑dollar monthly losses and a capital metric the board described as well below standard targets, risks the board said could ripple through hospitals and community providers.

Major points from the board’s briefing

- Scope and limits: Foster said the board lacks authority over Medicare and Medicaid rates and most self‑insured plans. The board’s regulatory levers are principally hospital budget review, limited insurer rate review for the qualified health plan market, ACO oversight and certificates of need.

- Total cost of care: The board explained Vermont participates in an all‑payer model and sets a Medicare total cost‑of‑care benchmark under the federal agreement. Foster described the benchmark as a range the state chooses each year and said the board typically selects the top of the allowable range to maximize federal draw‑down opportunities under the ACO arrangement.

- Affordability and access: The board highlighted long specialist wait times reported in a state study (state average ~48 days), rising individual insurance premiums (the presentation noted the lowest‑cost silver plan’s premium increases) and families facing very high total premium and out‑of‑pocket exposure. Foster said a commonly used example from the slides showed a 2025 premium path that could put a family of four near $50,000 for platinum coverage before subsidies.

- Insurer and hospital finances: Foster described Blue Cross Blue Shield Vermont as “facing severe, severe, severe financial challenges,” citing monthly losses the board said were about $13 million in October and $10 million in December in the months referenced in the briefing and an RBC (risk‑based capital) measure the board listed at about 337 (the board presented a target range near 590–745). The board attributed much of the insurer gap to higher claims driven by utilization and very high local prices at some facilities.

- Hospital budgets and enforcement: The board reviewed its hospital budget process and recent decisions. As described in the briefing, the board approved a systemwide net patient revenue figure of about $3.7 billion and outlined recent years’ charge approvals and adjustments: the board described a prior systemwide charge increase of about 10.5% in one year, later approvals constrained to lower percentages, and more recent approvals closely tethered to board guidance. The board also described enforcement actions after budget overages: it said it required the University of Vermont Medical Center to reduce commercial rates by an amount equivalent to an identified overage (the figure cited in the presentation was about $88 million) and that Rutland’s overage was partially enforced (the transcript records the board enforced about half the Rutland overage).

- Community providers under stress: Foster warned that community health centers and nonhospital providers have falling days‑cash‑on‑hand and rising employer health costs; the presentation cited an FQHC projected to lose more than $2 million in FY25 and organizations that have seen employer health costs spike 60% to over 100% in recent years.

Board actions listed at the briefing (as presented)

- Hospital budget approvals and guidance: the board described approving hospital net patient revenue totaling roughly $3.7 billion and said recent approvals have been restricted relative to hospitals’ requests to align with state affordability goals (board described a year when hospitals requested ~10.6% systemwide and the board approved ~4.1%).

- Fiscal enforcement for budget overages: the board described ordering corrective measures after FY23 overages, including a reduction in commercial prices equivalent to an $88 million overage attributed to one major network (described in the presentation as UVM Medical Center) and a partial enforcement for Rutland (about half of that hospital’s overage was enforced, per the presentation).

- Midyear solvency relief: the board said it granted a midyear commercial price increase (described in testimony as roughly 7–8%) to a small hospital that reported acute solvency concerns and low days cash on hand to prevent an immediate closure of local services.

Quotes and sourcing

Foster summarized the board’s mission and limits: “We do not regulate Medicare and Medicaid. We do not regulate Medicare Advantage Plans or self insured plans.” He warned that “you can't pay your way out of this problem” when describing the interaction of price increases, access and statewide affordability. Jennifer Cartag, legislative counsel from the Office of Legislative Council, told the committee that the state has statutory authority and levers that could be used to address some school and municipal plan designs but that those arrangements are complex and subject to collective bargaining and intermunicipal insurance rules.

What the board said it cannot do

The board repeatedly emphasized it cannot direct funding to providers it does not regulate (for example, most primary‑care practices and freestanding mental health providers) and does not control pharmaceutical prices or Medicare payment levels. Foster said the board has “regulatory authorities” but generally not funding authorities outside hospital rate and budget review.

Closing and next steps

Board members urged the committee to recognize tradeoffs: preserving local hospital services may raise costs elsewhere in the system and vice versa. Foster and other board speakers said the state must choose which reforms to pursue — reference‑based pricing, rate setting, global budgets or other structural change — and that any major rate‑setting reform would take significant time and resources to design and implement.

Votes at a glance (as described in the presentation): the board reported recent approvals that reduced hospital request levels, enforcement actions to remediate FY23 overages (including an $88 million equivalent reduction ordered against a network overage), and one or more midyear solvency‑related approvals for a small hospital that the board described as having very low cash on hand. The transcript provided these actions as the board’s summary of recent orders and enforcement; the official written orders for each hospital are posted by the board.